WHWK Earnings & Financial Statements
Whitehawk Therapeutics Inc
$2.97
-$0.05(-1.66%)
43
Overall
60
Value
18
Tech
52
Quality
Market Cap
$169.32M
Volume
510.06K
52W Range
$1.87 - $5.50
Target Price
$7.71
WHWK earnings and financial statements: Whitehawk Therapeutics Inc's income statement, balance sheet and cash flow statement, annual and quarterly.
WHWK Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $7.14M | $25.98M | $24.35M | $15.22M | $1.12M |
| Cost of revenue | $760.0K | $3.02M | $2.81M | $1.33M | - |
| Operating income | -$114.40M | -$67.46M | -$71.93M | -$62.68M | -$111.22M |
| EBITDA | -$24.95M | -$63.34M | -$65.36M | -$61.34M | -$109.32M |
| Net income | -$20.60M | -$63.69M | -$65.77M | -$60.51M | -$110.09M |
| EPS (diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $150.83M | $70.32M | $132.42M | $184.24M | $157.91M |
| Total liabilities | $14.52M | $17.84M | $27.23M | $25.86M | $21.50M |
| Shareholders’ equity | $136.31M | $52.48M | $105.19M | $158.38M | $136.41M |
| Cash and equivalents | $37.57M | $28.67M | $62.89M | $39.02M | $148.99M |
| Long-term debt | - | $565.0K | $833.0K | $1.27M | $474.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$97.43M | -$59.55M | -$59.66M | -$49.64M | -$22.42M |
| Capital expenditure | -$552.0K | -$1.65M | -$3.97M | -$444.0K | -$46.0K |
| Free cash flow | -$97.98M | -$61.20M | -$63.63M | -$50.08M | -$22.47M |
| Dividends paid | - | - | - | - | $4.41M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WHWK | $2.97 | -1.7% | 510.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Whitehawk Therapeutics Inc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW